Immodulon attended the 3rd annual Immuno‑Oncology 360° event taking place February 1st – 3rd, 2017 in New York.
Immuno-Oncology 360° is a global conference attracting national and international experts and thought leaders from large pharmaceuticals and small biotechnology companies to discuss clinical advancements, scientific data and business development.
Immodulon was an Executive Sponsor of the event and Chief Scientific Officer, Laura Rosa Brunet, gave a Quick-Fire presentation on flagship treatment IMM-101 which was well received.